Cite
HARVARD Citation
Prentice, R. et al. (2020). Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19. Alimentary pharmacology & therapeutics. 52 (8), pp. 1422-1423. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prentice, R. et al. (2020). Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19. Alimentary pharmacology & therapeutics. 52 (8), pp. 1422-1423. [Online].